Ally Bridge Group »

Cytomx Therapeutics shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2M 900k 4.70

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Praxis Precision Medicines I Com New (PRAX)
Minerva Neurosciences Com New (NERV)
Ovid Therapeutics (OVID)
Compass Pathways Sponsored Ads (CMPS)
Tarsus Pharmaceuticals (TARS)
Solid Biosciences Com New (SLDB)
Compass Therapeutics Call Option (CMPX)
Promis Neurosciences Com Shs (PMN)
Edgewise Therapeutics (EWTX)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Cytomx Therapeutics (CTMX)
Inventiva Sa Ads (IVA)
Perspective Therapeutics Com New (CATX)

View all positions for Ally Bridge Group

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
Bank of America Corporation
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Vanguard Group
Point72 Asset Management
Citadel Advisors
BlackRock
State Street Corporation
Baker Bros. Advisors
Elmind Capital
Nextech Invest
Financial Engines Advisors L.L.C

View all funds holding Cytomx Therapeutics